Johnson & Johnson's OTC sales rise by 4.1%

25 January 2017 - Deborah Wilkes


Worldwide OTC sales at Johnson & Johnson grew by 4.1% on an operational basis in the fourth quarter of 2016, thanks to a rise of 8.3% in the US.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: